메뉴 건너뛰기




Volumn 12, Issue 6, 2005, Pages 433-440

Changes in biochemical, hematological and immunological profiles after low-dose intravenous immunoglobulin administration in patients with hypogammaglobulinemia

Author keywords

Common variable immunodeficiency; Drug safety; Hypogammaglobunemia; Immunoglobulin replacement; Intravenous immunoglobulins

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CHOLESTEROL; IMMUNOGLOBULIN; PROTEIN; SODIUM; IMMUNOGLOBULIN A; PLASMA PROTEIN; SORBITOL;

EID: 33745175559     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2006.02.023     Document Type: Article
Times cited : (6)

References (43)
  • 1
    • 0142103746 scopus 로고    scopus 로고
    • Intravenous immune globulins: an update for clinicians
    • Knezevic-Maramica I., and Kruskall M.S. Intravenous immune globulins: an update for clinicians. Transfusion 43 10 (2003) 1460-1480
    • (2003) Transfusion , vol.43 , Issue.10 , pp. 1460-1480
    • Knezevic-Maramica, I.1    Kruskall, M.S.2
  • 2
    • 0142217518 scopus 로고    scopus 로고
    • Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    • Bayry J., Thirion M., Misra N., Thorenoor N., Delignat S., et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurol. Sci. 24 Suppl 4 (2003) S217-S221
    • (2003) Neurol. Sci. , vol.24 , Issue.SUPPL. 4
    • Bayry, J.1    Thirion, M.2    Misra, N.3    Thorenoor, N.4    Delignat, S.5
  • 3
    • 0038377261 scopus 로고    scopus 로고
    • Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
    • Bayry J., Misra N., Latry V., Prost F., Delignat S., et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus. Clin. Biol. 10 3 (2003) 165-169
    • (2003) Transfus. Clin. Biol. , vol.10 , Issue.3 , pp. 165-169
    • Bayry, J.1    Misra, N.2    Latry, V.3    Prost, F.4    Delignat, S.5
  • 5
    • 0021972020 scopus 로고
    • Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease
    • Roifman C.M., Lederman H.M., Lavi S., Stein L.D., Levison H., et al. Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am. J. Med. 79 (1985) 171-174
    • (1985) Am. J. Med. , vol.79 , pp. 171-174
    • Roifman, C.M.1    Lederman, H.M.2    Lavi, S.3    Stein, L.D.4    Levison, H.5
  • 6
    • 0036286074 scopus 로고    scopus 로고
    • Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
    • Busse P.J., Razvi S., and Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 109 6 (2002) 1001-1004
    • (2002) J. Allergy Clin. Immunol. , vol.109 , Issue.6 , pp. 1001-1004
    • Busse, P.J.1    Razvi, S.2    Cunningham-Rundles, C.3
  • 7
    • 2342634251 scopus 로고    scopus 로고
    • Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency
    • de Gracia J., Vendrell M., Alvarez A., Pallisa E., Rodrigo M.J., et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. Int. Immunopharmacol. 4 6 (2004) 745-753
    • (2004) Int. Immunopharmacol. , vol.4 , Issue.6 , pp. 745-753
    • de Gracia, J.1    Vendrell, M.2    Alvarez, A.3    Pallisa, E.4    Rodrigo, M.J.5
  • 8
    • 0035818044 scopus 로고    scopus 로고
    • Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin
    • Kazatchkine M.D., and Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med. 345 (2001) 747-755
    • (2001) N. Engl. J. Med. , vol.345 , pp. 747-755
    • Kazatchkine, M.D.1    Kaveri, S.V.2
  • 9
    • 0021702429 scopus 로고
    • High-dose intravenous gammaglobulin for Kawasaki disease
    • Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2 8411 (1984) 1055-1058
    • (1984) Lancet , vol.2 , Issue.8411 , pp. 1055-1058
    • Furusho, K.1    Kamiya, T.2    Nakano, H.3    Kiyosawa, N.4    Shinomiya, K.5
  • 10
    • 0019463420 scopus 로고
    • High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood
    • Imbach P., Barandun S., d'Apuzzo V., Baumgartner C., Hirt A., et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1 8232 (1981) 1228-1231
    • (1981) Lancet , vol.1 , Issue.8232 , pp. 1228-1231
    • Imbach, P.1    Barandun, S.2    d'Apuzzo, V.3    Baumgartner, C.4    Hirt, A.5
  • 11
    • 0042667057 scopus 로고    scopus 로고
    • Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin
    • Immunology Nurses Study.
    • Brennan V.M., Salome-Bentley N.J., Chapel H.M., and Immunology Nurses Study. Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin. Clin. Exp. Immunol. 133 2 (2003) 247-251
    • (2003) Clin. Exp. Immunol. , vol.133 , Issue.2 , pp. 247-251
    • Brennan, V.M.1    Salome-Bentley, N.J.2    Chapel, H.M.3
  • 12
    • 0027522107 scopus 로고
    • Adverse effects of intravenous immunoglobulin
    • Misbah S.A., and Chapel H.M. Adverse effects of intravenous immunoglobulin. Drug Saf. 9 4 (1993) 254-262
    • (1993) Drug Saf. , vol.9 , Issue.4 , pp. 254-262
    • Misbah, S.A.1    Chapel, H.M.2
  • 13
    • 0142178203 scopus 로고    scopus 로고
    • Risks associated with the use of intravenous immunoglobulin
    • Pierce L.R., and Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus. Med. Rev. 17 4 (2003) 241-251
    • (2003) Transfus. Med. Rev. , vol.17 , Issue.4 , pp. 241-251
    • Pierce, L.R.1    Jain, N.2
  • 14
    • 0141721039 scopus 로고    scopus 로고
    • Therapy with intravenous immunoglobulins: complications and side-effects
    • Wittstock M., Benecke R., and Zettl U.K. Therapy with intravenous immunoglobulins: complications and side-effects. Eur. Neurol. 50 3 (2003) 172-175
    • (2003) Eur. Neurol. , vol.50 , Issue.3 , pp. 172-175
    • Wittstock, M.1    Benecke, R.2    Zettl, U.K.3
  • 15
    • 0033982566 scopus 로고    scopus 로고
    • Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications
    • Go R.S., and Call T.G. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin. Proc. 75 (2000) 83-85
    • (2000) Mayo Clin. Proc. , vol.75 , pp. 83-85
    • Go, R.S.1    Call, T.G.2
  • 16
    • 0038623965 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia
    • Steinberger B.A., Ford S.M., and Coleman T.A. Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia. Am. J. Hematol. 73 2 (2003) 97-100
    • (2003) Am. J. Hematol. , vol.73 , Issue.2 , pp. 97-100
    • Steinberger, B.A.1    Ford, S.M.2    Coleman, T.A.3
  • 17
    • 0028273062 scopus 로고
    • High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events
    • (107)
    • Dalakas M.C. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology 44 (1994) 223-226 (107)
    • (1994) Neurology , vol.44 , pp. 223-226
    • Dalakas, M.C.1
  • 18
    • 0033692697 scopus 로고    scopus 로고
    • Nephrotoxicity of intravenous immunoglobulin
    • Levy J.B., and Pusey C.D. Nephrotoxicity of intravenous immunoglobulin. QJM 93 11 (2000) 751-755
    • (2000) QJM , vol.93 , Issue.11 , pp. 751-755
    • Levy, J.B.1    Pusey, C.D.2
  • 19
    • 0038240601 scopus 로고    scopus 로고
    • The clinical features of 16 cases of stroke associated with administration of IVIg
    • Caress J.B., Cartwright M.S., Donofrio P.D., and Peacock Jr. J.E. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 60 11 (2003) 1822-1824
    • (2003) Neurology , vol.60 , Issue.11 , pp. 1822-1824
    • Caress, J.B.1    Cartwright, M.S.2    Donofrio, P.D.3    Peacock Jr., J.E.4
  • 20
    • 0036196289 scopus 로고    scopus 로고
    • Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease
    • Lee K.Y., Han J.W., Lee J.S., and Whang K.T. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Pediatr 91 (2002) 164-167
    • (2002) Acta Pediatr , vol.91 , pp. 164-167
    • Lee, K.Y.1    Han, J.W.2    Lee, J.S.3    Whang, K.T.4
  • 21
    • 0030753782 scopus 로고    scopus 로고
    • Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases
    • Koffman B.M., and Dalakas M.C. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 20 9 (1997) 1102-1107
    • (1997) Muscle Nerve , vol.20 , Issue.9 , pp. 1102-1107
    • Koffman, B.M.1    Dalakas, M.C.2
  • 22
    • 0030443450 scopus 로고    scopus 로고
    • Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease
    • Lee H.K., Kim D.S., Noh G.W., and Lee K.Y. Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease. Yonsei Med. J. 37 5 (1996) 357-363
    • (1996) Yonsei Med. J. , vol.37 , Issue.5 , pp. 357-363
    • Lee, H.K.1    Kim, D.S.2    Noh, G.W.3    Lee, K.Y.4
  • 23
    • 0031032706 scopus 로고    scopus 로고
    • Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo
    • Aukrust P., Muller F., Nordoy I., Haug C.J., and Froland S.S. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo. Clin. Exp. Immunol. 107 1 (1997) 50-56
    • (1997) Clin. Exp. Immunol. , vol.107 , Issue.1 , pp. 50-56
    • Aukrust, P.1    Muller, F.2    Nordoy, I.3    Haug, C.J.4    Froland, S.S.5
  • 25
    • 0032149583 scopus 로고    scopus 로고
    • Metabolic and hematologic changes occurring after rapid intravenous infusion of gammaglobulin in patients with antibody deficiency syndromes
    • Costa-Carvalho B.T., Lin M., Solé D., Carneiro-Sampaiao M.M.S., Sorensen R.U., and Naspitz C.K. Metabolic and hematologic changes occurring after rapid intravenous infusion of gammaglobulin in patients with antibody deficiency syndromes. Rev. Paul. Med. 116 5 (1998) 1815-1820
    • (1998) Rev. Paul. Med. , vol.116 , Issue.5 , pp. 1815-1820
    • Costa-Carvalho, B.T.1    Lin, M.2    Solé, D.3    Carneiro-Sampaiao, M.M.S.4    Sorensen, R.U.5    Naspitz, C.K.6
  • 26
    • 0027731524 scopus 로고
    • Elimination of infectious antigens and increase of IgG catabolism as possible mode of action of IVIg
    • Masson P.L. Elimination of infectious antigens and increase of IgG catabolism as possible mode of action of IVIg. J. Autoimmun. 6 (1993) 683-689
    • (1993) J. Autoimmun. , vol.6 , pp. 683-689
    • Masson, P.L.1
  • 27
    • 0033590571 scopus 로고    scopus 로고
    • Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases
    • Yu Z., and Lennon V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N. Engl. J. Med. 340 3 (1999) 227-228
    • (1999) N. Engl. J. Med. , vol.340 , Issue.3 , pp. 227-228
    • Yu, Z.1    Lennon, V.A.2
  • 28
    • 0035892141 scopus 로고    scopus 로고
    • Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect
    • Bleeker W.K., Teeling J.L., and Hack C.E. Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect. Blood 98 10 (2001) 3136-3142
    • (2001) Blood , vol.98 , Issue.10 , pp. 3136-3142
    • Bleeker, W.K.1    Teeling, J.L.2    Hack, C.E.3
  • 29
    • 0032572931 scopus 로고    scopus 로고
    • Intravenous immune globulin and pseudohyponatremia
    • Lawn N., Wijdicks E.F., and Burritt M.F. Intravenous immune globulin and pseudohyponatremia. N. Engl. J. Med. 339 9 (1998) 632
    • (1998) N. Engl. J. Med. , vol.339 , Issue.9 , pp. 632
    • Lawn, N.1    Wijdicks, E.F.2    Burritt, M.F.3
  • 30
    • 0037445605 scopus 로고    scopus 로고
    • Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy
    • Ochi K., Kohriyama T., Higaki M., Ikeda J., Harada A., et al. Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy. J. Neurol. Sci. 208 1-2 (2003) 43-50
    • (2003) J. Neurol. Sci. , vol.208 , Issue.1-2 , pp. 43-50
    • Ochi, K.1    Kohriyama, T.2    Higaki, M.3    Ikeda, J.4    Harada, A.5
  • 31
    • 0032860475 scopus 로고    scopus 로고
    • Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment
    • Schiller B., and Elinder G. Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr. 88 8 (1999) 844-848
    • (1999) Acta Paediatr. , vol.88 , Issue.8 , pp. 844-848
    • Schiller, B.1    Elinder, G.2
  • 32
    • 0035660153 scopus 로고    scopus 로고
    • Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis
    • Noh G., and Lozano F. Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis. Clin. Exp. Allergy 31 12 (2001) 1932-1938
    • (2001) Clin. Exp. Allergy , vol.31 , Issue.12 , pp. 1932-1938
    • Noh, G.1    Lozano, F.2
  • 33
    • 0031836298 scopus 로고    scopus 로고
    • Intravenous immunoglobulin induced nephropathy: a complication of IVIG therapy
    • Ahsan N. Intravenous immunoglobulin induced nephropathy: a complication of IVIG therapy. J. Nephrol. 11 3 (1998) 157-161
    • (1998) J. Nephrol. , vol.11 , Issue.3 , pp. 157-161
    • Ahsan, N.1
  • 34
    • 0347651357 scopus 로고    scopus 로고
    • Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura
    • Blanchette V., and Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus. Sci. 19 (1998) 279-288
    • (1998) Transfus. Sci. , vol.19 , pp. 279-288
    • Blanchette, V.1    Carcao, M.2
  • 35
    • 0037410194 scopus 로고    scopus 로고
    • Mechanism of action of IVIG and anti-D in ITP
    • Lazarus A.H., and Crow A.R. Mechanism of action of IVIG and anti-D in ITP. Transfus. Apheresis Sci. 28 3 (2003) 249-255
    • (2003) Transfus. Apheresis Sci. , vol.28 , Issue.3 , pp. 249-255
    • Lazarus, A.H.1    Crow, A.R.2
  • 36
    • 0035883092 scopus 로고    scopus 로고
    • Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia
    • Teeling J.L., Jansen-Hendriks T., Kuijpers T.W., de Haas M., van de Winkel J.G., et al. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 98 4 (2001) 1095-1099
    • (2001) Blood , vol.98 , Issue.4 , pp. 1095-1099
    • Teeling, J.L.1    Jansen-Hendriks, T.2    Kuijpers, T.W.3    de Haas, M.4    van de Winkel, J.G.5
  • 37
    • 0036264375 scopus 로고    scopus 로고
    • Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease
    • Tsujimoto H., Takeshita S., Nakatani K., Kawamura Y., Tokutomi T., et al. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin. Immunol. 103 2 (2002) 161-168
    • (2002) Clin. Immunol. , vol.103 , Issue.2 , pp. 161-168
    • Tsujimoto, H.1    Takeshita, S.2    Nakatani, K.3    Kawamura, Y.4    Tokutomi, T.5
  • 38
    • 0025666414 scopus 로고
    • CD4 and CD8 subpopulation changes during hig dose intravenous immunoglobulin treatment
    • Macey M.G., and Newland A.C. CD4 and CD8 subpopulation changes during hig dose intravenous immunoglobulin treatment. Br. J. Haematol. 76 (1990) 513-520
    • (1990) Br. J. Haematol. , vol.76 , pp. 513-520
    • Macey, M.G.1    Newland, A.C.2
  • 40
    • 0037296040 scopus 로고    scopus 로고
    • Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells
    • Toyoda M., Pao A., Petrosian A., and Jordan S.C. Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells. Am. J. Transplant. 3 (2003) 156-166
    • (2003) Am. J. Transplant. , vol.3 , pp. 156-166
    • Toyoda, M.1    Pao, A.2    Petrosian, A.3    Jordan, S.C.4
  • 41
    • 0037204949 scopus 로고    scopus 로고
    • B cell antigen receptor signaling: roles in cell development and disease
    • Gauld S.B., Dal Porto M., and Cambier J.C. B cell antigen receptor signaling: roles in cell development and disease. Science 296 (2002) 1641-1642
    • (2002) Science , vol.296 , pp. 1641-1642
    • Gauld, S.B.1    Dal Porto, M.2    Cambier, J.C.3
  • 42
    • 0038487093 scopus 로고    scopus 로고
    • Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases
    • Bossowski A., Urban M., and Stasiak-Barmuta A. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases. J. Pediatr. Endocrinol. Metab. 16 1 (2003) 63-70
    • (2003) J. Pediatr. Endocrinol. Metab. , vol.16 , Issue.1 , pp. 63-70
    • Bossowski, A.1    Urban, M.2    Stasiak-Barmuta, A.3
  • 43
    • 0034544489 scopus 로고    scopus 로고
    • Quantitative genetic variation in CD19 expression correlates with autoimmunity
    • Sato S., Hasegawa M., Fujimoto M., Tedder T.F., and Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165 11 (2000) 6635-6643
    • (2000) J. Immunol. , vol.165 , Issue.11 , pp. 6635-6643
    • Sato, S.1    Hasegawa, M.2    Fujimoto, M.3    Tedder, T.F.4    Takehara, K.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.